What are the VA rating percentages for Benign Prostatic Hyperplasia (BPH)?

Benign Prostatic Hyperplasia (BPH) (DC 7527) is rated at 10%, 20%, 40%, 60% under 38 CFR § 4.115b, DC 7527. Daytime voiding interval between two and three hours, or awakening to void two times per night; or mild renal dysfunction.

What rates 10% for Benign Prostatic Hyperplasia (BPH) under 38 CFR § 4.115b, DC 7527?

Under 38 CFR § 4.115b, DC 7527 (DC 7527), a 10% rating for Benign Prostatic Hyperplasia (BPH) requires: Daytime voiding interval between two and three hours, or awakening to void two times per night; or mild renal dysfunction.

What secondary conditions are linked to Benign Prostatic Hyperplasia (BPH)?

Common secondary conditions for Benign Prostatic Hyperplasia (BPH) include Urinary Tract Infections, Bladder Stones, Kidney Damage, Sleep Disturbance. Secondary service connection is established under 38 C.F.R. 3.310 when a condition is caused or aggravated by an already service-connected disability.

← All Condition Guides

CLAIMRECON INTEL

Benign Prostatic Hyperplasia (BPH)

Q: What rates 20% for Benign Prostatic Hyperplasia (BPH) under 38 CFR § 4.115b, DC 7527?

Under 38 CFR § 4.115b, DC 7527 (DC 7527), a 20% rating for Benign Prostatic Hyperplasia (BPH) requires: Daytime voiding interval between one and two hours, or awakening to void three to four times per night; or requiring the wearing of absorbent materials which must be changed less than two times per day.

Q: What rates 40% for Benign Prostatic Hyperplasia (BPH) under 38 CFR § 4.115b, DC 7527?

Under 38 CFR § 4.115b, DC 7527 (DC 7527), a 40% rating for Benign Prostatic Hyperplasia (BPH) requires: Daytime voiding interval less than one hour, or awakening to void five or more times per night; or requiring the wearing of absorbent materials which must be changed two to four times per day.

Q: What rates 60% for Benign Prostatic Hyperplasia (BPH) under 38 CFR § 4.115b, DC 7527?

Under 38 CFR § 4.115b, DC 7527 (DC 7527), a 60% rating for Benign Prostatic Hyperplasia (BPH) requires: Requiring the use of an appliance or the wearing of absorbent materials which must be changed more than four times per day; or moderate to severe renal dysfunction.

Q: What evidence do I need for a Benign Prostatic Hyperplasia (BPH) VA claim?

Key evidence for a Benign Prostatic Hyperplasia (BPH) claim includes: A voiding diary recording pad/appliance changes per day, daytime voiding intervals, and nighttime awakenings; Lab reports showing GFR or eGFR across at least 3 consecutive months (renal dysfunction); Urology records showing post-void residual volume, uroflowmetry peak flow, or catheterization needs; Records of recurrent UTIs, including hospitalizations and any suppressive drug therapy; Imaging or operative reports confirming the genitourinary diagnosis. All evidence should document both the condition and its impact on daily functioning.

DC 752738 C.F.R. § 4.115b

Diagnostic Code

DC 7527

38 C.F.R. § 4.115b

Rating Range

10–60%

4 severity tiers

Source

Referenced

38 C.F.R. Part 4

Benign Prostatic Hyperplasia (BPH) is rated by the U.S. Department of Veterans Affairs under DC 7527 of 38 CFR § 4.115b, DC 7527 across 4 severity tiers (10% / 20% / 40% / 60%). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303. This condition is frequently rated as secondary to Urinary Tract Infections or Bladder Stones under 38 C.F.R. § 3.310.

Educational tool only. Not legal or medical advice. Not affiliated with the VA.

Overview

Non-cancerous enlargement of the prostate gland that compresses the urethra and causes lower urinary tract symptoms (LUTS): urinary frequency, urgency, nocturia, weak stream, incomplete emptying, hesitancy, and post-void dribbling. Extremely common in older male veterans (50%+ prevalence over age 60). Often comorbid with obesity, diabetes, and metabolic syndrome. Treatment ranges from watchful waiting → alpha-blockers (tamsulosin) → 5-alpha-reductase inhibitors (finasteride) → minimally invasive procedures (UroLift, Rezum) → TURP/HoLEP surgery.

Rating Criteria

10%

Daytime voiding interval between two and three hours, or awakening to void two times per night; or mild renal dysfunction.

20%

Daytime voiding interval between one and two hours, or awakening to void three to four times per night; or requiring the wearing of absorbent materials which must be changed less than two times per day.

40%

Daytime voiding interval less than one hour, or awakening to void five or more times per night; or requiring the wearing of absorbent materials which must be changed two to four times per day.

60%

Requiring the use of an appliance or the wearing of absorbent materials which must be changed more than four times per day; or moderate to severe renal dysfunction.

Key Evidence

—A voiding diary recording pad/appliance changes per day, daytime voiding intervals, and nighttime awakenings

—Lab reports showing GFR or eGFR across at least 3 consecutive months (renal dysfunction)

—Urology records showing post-void residual volume, uroflowmetry peak flow, or catheterization needs

—Records of recurrent UTIs, including hospitalizations and any suppressive drug therapy

—Imaging or operative reports confirming the genitourinary diagnosis

—Complete list of genitourinary medications

C&P Exam Tips

1If your condition causes voiding dysfunction, the rating often turns on absorbent materials or appliance use (38 CFR 4.115a) - count and report how many times per day you change a pad or appliance (more than 4x/day supports the highest level).

2For urinary frequency, document your daytime voiding interval and how many times you wake to void at night - both are explicit thresholds.

3For obstructed voiding, ask whether your record shows post-void residual volume, peak flow rate (uroflowmetry), or a need for catheterization.

4If the kidneys are involved, the rating is driven by GFR (38 CFR 4.115a) - request an eGFR lab and note that it must persist for at least 3 consecutive months in the past 12 months.

5For recurrent urinary tract infections, document drainage by stent/nephrostomy, hospitalizations per year, and any continuous/suppressive drug therapy.

6Report your worst days, bring a voiding diary, and describe how the condition affects sleep, work, and daily activity.

Secondary Conditions

Urinary Tract InfectionsMODERATE

Incomplete bladder emptying causes infections

Bladder StonesMODERATE

Urinary stasis promotes stone formation

Kidney DamageMODERATE

Chronic obstruction can damage kidneys

Sleep DisturbanceMODERATE

Nocturia disrupts sleep

More in Genitourinary

Bladder / Bowel Dysfunction Bladder Cancer Bladder Condition Bladder Dysfunction Chronic Cystitis Chronic Kidney Disease Chronic Kidney Disease Chronic Orchialgia (Chronic Testicular Pain)All Genitourinary conditions →All conditions →

Tools

Rating Calculator →Secondaries Explorer →C&P Exam Prep →PACT Act Scanner →2026 Rates →

Sources & Editorial

Rating criteria reference 38 C.F.R. Part 4 (Schedule for Rating Disabilities). This entry has not yet undergone editorial review against the live regulation text — consult the authoritative source directly before relying on the criteria shown.

View 38 C.F.R. Part 4 on eCFR →Editorial Standards →Suggest a correction →

EDUCATIONAL TOOL ONLY. NOT LEGAL OR MEDICAL ADVICE.
NOT AFFILIATED WITH THE U.S. DEPARTMENT OF VETERANS AFFAIRS.
CLAIMRECON 2026

LOADING